Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04205617
Other study ID # 13491
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 14, 2019
Est. completion date October 13, 2020

Study information

Verified date October 2020
Source Tufts University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is a pre/post, pilot evaluation of the 4-month, Living Hungry program for food-insecure patients with uncontrolled diabetes. The program provides free produce, whole grains and legumes to participants and their household every-other week, in addition, to nutrition education and glucose monitoring devices. The study is analyzing diabetes management indicators, including HbA1c, dietary quality, food insecurity, and medication adherence, plus health care utilization.


Description:

The Living Hungry Collaborative, in partnership with the South Florida Hunger Coalition, previously operated a pilot program, Fresh Food Farmacy, staged from June 1, 2018, to September 29, 2018. The program consisted of nine Eat Well Pop-Up Pantry events at the My Clinic in Jupiter, Florida, serving 104 patients and feeding approximately 300 people including their families. Each set of groceries contained two weeks' worth of "medically tailored" groceries for diabetic-friendly meals for food-insecure patients diagnosed with diabetes or prediabetes. All clients involved in the intervention were referred by staff at the same four clinics that will participate in this study: My Clinic, C.L. Brumback Clinic in Jupiter, Jupiter Medical Center, and FoundCare. The Living Hungry Collaborative has an ongoing program to further evolve and test the "Fresh Food Farmacy", renamed as the Healthy Food Prescription Program intervention in Palm Beach County, for food-insecure, diabetic patients. In addition to receiving diabetic appropriate groceries at the former Fresh Food Farmacy events, clients will be engaged in diabetes education classes led by volunteer doctors and nurses, cooking demonstrations, shared meals, 1:1 and group coaching by nutritionists and dietitians on best choices from a menu for diabetics, and tasting new recipes with produce from the pop-up event. The pilot program allowed Living Hungry to fine-tune the patient referral process, distribution logistics, and establish strong partnerships required for the next phase of the program. However, gaps exist to understand the extent to which the program design is improving the health of the participating diabetic patients. Living Hungry will partner with Tufts University to conduct an evaluation of this existing program on key health outcomes that concern the partner clinics, specifically: biomarkers including Hemoglobin A1C, BMI, blood pressure, lipid profile, health care utilization including medication use, hospitalizations, emergency department visits, and health care costs, plus dietary quality, food insecurity, medication use, and quality of life indicators. The study is a pilot evaluation, implementing a quasi-experimental, pre/post study design. The Living Hungry Healthy Foods Prescription Program is a community-based program that will be available to individuals whether or not they participate in the evaluation by Tufts University. This program is using the same referral and data collections procedures as the pilot, which include having physicians at the partner clinics refer patients with HbA1C levels greater than 8.0 mmol/mol and who are food insecure to Living Hungry to participate in the program. In addition, Living Hungry will again collect data on HbA1c, BMI, blood pressure, lipid profiles, and distribute a survey to participants.


Recruitment information / eligibility

Status Completed
Enrollment 35
Est. completion date October 13, 2020
Est. primary completion date July 25, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Referred patient from one of four medical partners: My Clinic, C.L. Brumback Clinic, FoundCare and Jupiter Medical Center and has been a patient for at least one-year. 2. Diabetic with A1C over 8.0 3. Adults 18 years of age or older 4. Food-insecure Exclusion Criteria: 1. Referred patients with HbA1c levels below 8.0 mmol/mol 2. Minors 3. Adults with severe mental illness who cannot provide informed consent, unless they have present a lawful caregiver or power of attorney. 4. Anyone who does not plan on staying in West Palm Beach for the next 4 months. 5. Pregnant women (can still receive services through the program but will not be included in the analysis)

Study Design


Related Conditions & MeSH terms


Intervention

Other:
produce prescription and nutrition education
Participants will receive diabetic appropriate groceries, diabetes education classes led by volunteer doctors and nurses, cooking demonstrations, shared meals, 1:1 and group coaching by dietitians.

Locations

Country Name City State
United States Living Hungry West Palm Beach Florida

Sponsors (7)

Lead Sponsor Collaborator
Tufts University FoundCare Inc., Health Care District of Palm Beach County, Jupiter Medical Center, Living Hungry, Inc., MyClinic, Inc, South Florida Hunger Coalition

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Hemoglobin A1c will be measured by blood draws at first and last program event pre/post change in HbA1c in participants from baseline to completion of the program at 4 months
Secondary Change in frequency of hospitalizations will be measured through surveys and data from electronic medical records pre/post change in hospitalizations in participants from baseline to one month after completion of the program
Secondary Change in frequency of emergency department admissions will be measured through surveys and data from electronic medical records pre/post change in emergency department admissions in participants from baseline to one month after completion of the program
Secondary Change in total health care costs will be measured through data from hospital records pre/post change in total health care costs in participants from baseline to one month after completion of the program
Secondary Change in food insecurity Food insecurity will be measured using the USDA 9-question food insecurity screener pre/post change in food insecurity in participants from baseline to completion of the program at 4 months
Secondary Change in daily servings of fruits and vegetables Will be assessed through a food frequency questionnaire modeled off the USDA FINI assessment tool pre/post change in daily servings of fruits and vegetables in participants from baseline to completion of the program at 4 months
Secondary Change in daily servings of whole grains Will be assessed through a food frequency questionnaire modeled off the USDA FINI assessment tool pre/post change in daily servings of whole grains in participants from baseline to completion of the program at 4 months
Secondary Change in daily servings of lean proteins Will be assessed through a food frequency questionnaire modeled off the USDA FINI assessment tool and includes: nuts, seeds, legumes, poultry, and fish. pre/post change in daily servings of lean proteins in participants from baseline to completion of the program at 4 months
Secondary Change in daily servings of sugary snacks and drinks Will be assessed through a food frequency questionnaire modeled off the USDA FINI assessment tool and includes: sugar sweetened beverages, pastries, cookies, cakes, candy, and other sweets pre/post change in daily servings of sugary snacks and drinks in participants from baseline to completion of the program at 4 months
Secondary Change in medication adherence Measured as a composite score that will be assessed through a survey. Components include: frequency of sacrificing medication purchases for other household needs (such as food, utilities) and change in medication use. pre/post change in medication adherence in participants from baseline to completion of the program at 4 months
Secondary Change in adhering to recommended diabetes management plan Measured as a composite scale that will be assessed through a survey. Components include frequency in which participants followed the recommendations of their physicians to manage their diabetes. pre/post change in in adhering to recommended diabetes management in participants from baseline to completion of the program at 4 months
Secondary Change in blood LDL level measured at first and last program event through a blood draw pre/post change in systolic blood LDL levels in participants from baseline to completion of the program at 4 months
Secondary Change in systolic blood pressure measured at first and last program event pre/post change in systolic blood pressure in participants from baseline to completion of the program at 4 months
Secondary Change in diastolic blood pressure measured at first and last program event pre/post change in diastolic blood pressure in participants from baseline to completion of the program at 4 months
See also
  Status Clinical Trial Phase
Completed NCT03743779 - Mastering Diabetes Pilot Study
Completed NCT03786978 - Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus N/A
Completed NCT01804803 - DIgital Assisted MONitoring for DiabeteS - I N/A
Completed NCT05039970 - A Real-World Study of a Mobile Device-based Serious Health Game on Session Attendance in the National Diabetes Prevention Program N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT04068272 - Safety of Bosentan in Type II Diabetic Patients Phase 1
Completed NCT03243383 - Readmission Prevention Pilot Trial in Diabetes Patients N/A
Completed NCT03730480 - User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS) N/A
Recruiting NCT02690467 - Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm. N/A
Completed NCT02229383 - Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus Phase 3
Completed NCT05799976 - Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure N/A
Completed NCT06181721 - Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes N/A
Recruiting NCT04489043 - Exercise, Prediabetes and Diabetes After Renal Transplantation. N/A
Withdrawn NCT03319784 - Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients Phase 4
Completed NCT03542084 - Endocrinology Auto-Triggered e-Consults N/A
Completed NCT02229396 - Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo Phase 3
Recruiting NCT05544266 - Rare and Atypical Diabetes Network
Completed NCT01892319 - An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
Completed NCT05031000 - Blood Glucose Monitoring Systems: Discounter Versus Brand N/A
Recruiting NCT04039763 - RT-CGM in Young Adults at Risk of DKA N/A